Susquehanna International Group
JAGX icon

Susquehanna International Group’s Jaguar Health JAGX Stock Holding History

Susquehanna International Group’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– -$3K – 13042
2022
Q3 		– Hold
0
– – – 12922
2022
Q2 		– Hold
0
– – – 12591
2022
Q1 		– Hold
0
– – – 12715
2021
Q4 		– Hold
0
– – – 12540
2021
Q3 		– Hold
0
– – – 11177
2021
Q2 		– Hold
0
– – – 11479
2021
Q1 		– Hold
0
– – – 10149

Other funds holding JAGX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Susquehanna International Group's JAGX Position: Q1 2025 in Review

Susquehanna International Group sold out of Jaguar Health (JAGX) in Q1 2025, closing a stake of 14 shares — an estimated $11.6K sold.

Susquehanna International Group first reported a position in JAGX in Q1 2024 and held it in 2 quarters. The position peaked at $14.1K in Q1 2024. 4 funds tracked by Wall St. Rank hold JAGX as of Q1 2025.

  • Susquehanna International Group reported no remaining Jaguar Health position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 14 Jaguar Health shares in Q1 2025, an estimated $11.6K.
  • Susquehanna International Group first reported a position in Jaguar Health in Q1 2024 and held it in 2 quarters.
  • Susquehanna International Group's Jaguar Health position peaked at $14.1K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.